Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 4/3/2026 | Buy → Hold | Erste Group | ||
| 4/2/2026 | Buy → Hold | Erste Group | ||
| 3/30/2026 | $825.00 → $775.00 | Overweight | Morgan Stanley | |
| 3/18/2026 | $12.00 | Buy | Truist | |
| 3/5/2026 | Buy → Neutral | Arete | ||
| 3/5/2026 | Hold → Buy | Erste Group | ||
| 3/4/2026 | $460.00 | Buy | BofA Securities | |
| 2/23/2026 | $849.00 → $856.00 | Overweight | Wells Fargo |
4 - Altimmune, Inc. (0001326190) (Issuer)
4 - Altimmune, Inc. (0001326190) (Issuer)
4 - Altimmune, Inc. (0001326190) (Issuer)
4 - Altimmune, Inc. (0001326190) (Issuer)
4 - Tesla, Inc. (0001318605) (Issuer)
AUSTIN, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: As regulatory expectations intensify and manufacturing complexity grows, pharmaceutical companies are moving beyond traditional quality systems toward a new paradigm: embedding artificial intelligence (AI) directly into operations as a real-time compliance layer. Rather than relying on retrospective audits and manual oversight, AI-driven systems now continuously monitor, validate and optimize production processes to align with evolving Good Manufacturing Practice (GMP) standards. This structural shift is increasingly visible across the industry and aligns with companies such as Oncotelic Therapeutics Inc. (OTC
Nvidia's top 1% AI engineer leaves world's most valuable company to lead self-storage's first Chief AI Officer role at 10 FederalRALEIGH, N.C., April 6, 2026 /PRNewswire/ -- 10 Federal, a leading technology-driven self-storage owner and operator, today announced the appointment of Christopher Taylor as its Chief A.I. Officer (CAIO), a newly created executive position that represents the first dedicated C-suite AI role in the self-storage industry. Taylor joins 10 Federal from Nvidia (NASDAQ:NVDA), the global leader in AI computing, where he served as a Senior Software Engineer working across both the data center division and the autonomous vehicle platform, and ranked among the top 1% of AI
In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026 Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin
8-K/A - Aditxt, Inc. (0001726711) (Filer)
DEF 14A - Aditxt, Inc. (0001726711) (Filer)
8-K - Aditxt, Inc. (0001726711) (Filer)
Erste Group downgraded Meta Platforms from Buy to Hold
Erste Group downgraded Meta Platforms from Buy to Hold
Morgan Stanley reiterated coverage of Meta Platforms with a rating of Overweight and set a new price target of $775.00 from $825.00 previously
Nvidia's top 1% AI engineer leaves world's most valuable company to lead self-storage's first Chief AI Officer role at 10 FederalRALEIGH, N.C., April 6, 2026 /PRNewswire/ -- 10 Federal, a leading technology-driven self-storage owner and operator, today announced the appointment of Christopher Taylor as its Chief A.I. Officer (CAIO), a newly created executive position that represents the first dedicated C-suite AI role in the self-storage industry. Taylor joins 10 Federal from Nvidia (NASDAQ:NVDA), the global leader in AI computing, where he served as a Senior Software Engineer working across both the data center division and the autonomous vehicle platform, and ranked among the top 1% of AI
Busch brings public company leadership and capital markets experience to support Ignite's next phase of growth Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most
Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S
In the first quarter, we produced over 408,000 vehicles, delivered over 358,000 vehicles and deployed 8.8 GWh of energy storage products. Thank you to all of our customers, employees, suppliers, shareholders and supporters who helped us achieve these results. Q1 2026 Production Deliveries Subject to operating lease accounting Model 3/Y 394,611 341,893 1% Other Models 13,775 16,130 2% Total 408,386 358,023 1% Tesla will post its financial results for the first quarter of 2026 after market close on Wednesday, April 22, 2026. At that time, Tesla will issue a brief advisory containin
Ignite plans to launch a new program in 2026 supporting treatment selection for more than 600,000 people in the United States living with metastatic cancer and limited therapeutic options. Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC ("Ignite"), a commercial-stage precision oncology company focused on addressing a critical challenge in cancer care: optimizing therapy selection. Ignite's functional proteomics platform has demonstrated the ability to identify cancer therapy responses that may not be captured by standard genomic testing alone. Aditxt
GAITHERSBURG, Md., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that it will report its fourth quarter 2025 financial results on Thursday, March 5, 2026. Altimmune management will host a conference call at 8:30 a.m. ET on March 5 to discuss the financial results and provide a business update. The conference call will be webcast live on Altimmune's Investor Relations website at https://ir.altimmune.com/investors. Participants who would like to join the call may register here to receive dial-in numbers and a unique PIN. A replay will be available on t
SC 13G - NeuroBo Pharmaceuticals, Inc. (0001638287) (Subject)
SC 13G/A - Altimmune, Inc. (0001326190) (Subject)
SC 13G/A - NVIDIA CORP (0001045810) (Subject)